Milestone Scientific Provides Business Update and Reports Financial Results for the Second Quarter of 2024GlobeNewsWire • 08/15/24
Milestone Scientific Schedules Second Quarter 2024 Financial Results and Business Update Conference CallGlobeNewsWire • 08/12/24
Milestone Scientific Announces Strategic Partnership with Axial Biologics to Distribute CompuFlo® in New Jersey, Texas, and FloridaGlobeNewsWire • 08/07/24
Milestone Scientific Announces Medicare Price Assignment for the CompuFlo® Epidural System in Texas, Pennsylvania, New Jersey, Maryland, Colorado, Oklahoma, Louisiana, Arkansas, Mississippi, New Mexico, District of Columbia, and DelawareGlobeNewsWire • 07/23/24
Milestone Scientific Receives Regulatory Approval to Market CompuFlo® Epidural System in BrazilGlobeNewsWire • 06/18/24
Milestone Scientific Reports Revenue of $2.2 Million and Provides Business Update for the First Quarter of 2024GlobeNewsWire • 05/16/24
Milestone Scientific Schedules First Quarter 2024 Financial Results and Business Update Conference CallGlobeNewsWire • 05/13/24
Milestone Scientific Achieves 12% Increase in Revenue and 39% Increase in Gross Profit for the Year Ended 2023GlobeNewsWire • 04/01/24
Milestone Scientific Schedules 2023 Year-End Financial Results and Business Update Conference CallGlobeNewsWire • 03/28/24
Milestone Scientific Commences Sales of CompuFlo® Epidural Disposables within Omaha Pain PhysiciansGlobeNewsWire • 03/14/24
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® with Meridian Endo & PerioGlobeNewsWire • 02/28/24
Milestone Scientific Commences Direct Sales of STA Single Tooth Anesthesia System® to Maine Dental Group, a Premier Group Practice with 21 Locations Across the NortheastGlobeNewsWire • 02/20/24
Milestone Scientific CEO Provides Letter to Shareholders; Provides Positive Reimbursement UpdateGlobeNewsWire • 01/16/24
Milestone Scientific Inc. Announces Closing of $3.0 Million Public Offering of Common StockGlobeNewsWire • 12/13/23
Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common StockGlobeNewsWire • 12/11/23
Milestone Scientific Commences Sales of CompuFlo® Disposables for Use in Neurostimulation Spinal Cord Implantation ProceduresGlobeNewsWire • 12/08/23
Milestone Announces Agreement with Bioline Supply to Distribute the CompuFlo® Epidural System and Related Disposables Across SpainGlobeNewsWire • 11/28/23
Milestone Scientific Achieves Revenue of $2.1 Million and Provides Business Update for the Third Quarter of 2023GlobeNewsWire • 11/15/23